[PDF][PDF] Divergent Actions of Pyruvate and ATP in Glucose-mediated Irinotecan Chemoresistance in Colorectal Cancer

CY Huang, YC Pai, LCH Yu - 2021 - scholar.archive.org
Background: Altered glucose metabolism is associated with chemoresistance in colorectal
cancer (CRC). The aim of this study was to illustrate the molecular mechanisms of glucose …

[PDF][PDF] Molecular Oncology of Colorectal Cancers Prognosis and Prediction, Radiation Oncologist Perspective

MMQ Baig, A Goel - 2022 - researchgate.net
Colorectal cancers (CRC) are a common cancer globally. The commonest symptoms were
rectal bleeding (57%), pain (44%), and altered bowel habits (26%). 13 percent of the …

[PDF][PDF] Predicting the Response to Radiotherapy for Rectal Cancer

J Fischer - 2019 - ourarchive.otago.ac.nz
Predicting the Response to Radiotherapy for Rectal Cancer Page 1 Predicting the Response
to Radiotherapy for Rectal Cancer Dr Jesse Fischer A thesis submitted for the degree of Master …

Synthèse totale, révision structurale et histoire naturelle des cytochalasines de petite taille: les périconiasines

M Zaghouani - 2016 - theses.hal.science
Les cytochalasines, métabolites secondaires issus de PKS-NRPS fongiques, représentent
une large famille de composés bioactifs intéressants de par leur système tricyclique. Ce …

Tumor Glycolysis as a Target for Cancer Diagnosis and Therapy

W Seubwai - Srinagarind Medical Journal, 2015 - li01.tci-thaijo.org
Altered energy metabolism in cancer cells were discovered in over 80 years ago, Otto
Warburg discovered that cancer cells predominantly produce energy (adenosine …

[PDF][PDF] The role of SLIRP and Notch signalling in colorectal cancer

PA Candy - 2013 - research-repository.uwa.edu.au
Colorectal cancer (CRC) is the third most common malignancy and the second highest
cause of cancer death, accounting for more than 4000 Australians deaths per year. The …

Preclinical Evaluation of Oral Metronomic Topotecan and Pazopanib for the Treatment of Aggressive Extracranial Pediatric Solid Tumors

S Kumar - 2013 - library-archives.canada.ca
Abstract Low Dose Metronomic (LDM) chemotherapy, combined with VEGF pathway
inhibitors, is a highly effective strategy to coordinately inhibit angiogenesis and tumor …